R. Vree
Impact in
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
-
- Colorectal Cancer Screening and Detection
- Colorectal Cancer Surgical Treatments
- Cancer survivorship and care
Papers in
- Oncology 4
- Cancer survivorship and care 2
- Colorectal Cancer Surgical Treatments 1
-
- Pharmacogenetics and Drug Metabolism 3
- Inflammatory mediators and NSAID effects 3
- Co-authors
- J. Kievit (4 shared papers)Anne M. Stiggelbout (3 shared papers)JCJM de Haes (1 shared paper)K. van Groningen (1 shared paper)Wendeline J. van der Made (2 shared papers)Joyce Dijs-Elsinga (3 shared papers)H.J. Smeets (2 shared papers)Wilma Otten (2 shared papers)
- Journals
- BMJ Quality & Safety (1 paper)British Journal of Cancer (1 paper)Journal of Clinical Oncology (1 paper)Breast Cancer Research and Treatment (1 paper)Quality of Life Research (1 paper)
- Partner nations
- NetherlandsBelgium
In The Last Decade
R. Vree
12 papers receiving 360 citations
Peers
Comparison fields: 5 of 69
- Pharmacology 60
- Oncology 181
- Family Practice 9
- General Health Professions 87
- Pathology and Forensic Medicine 44
Countries citing papers authored by R. Vree
This map shows the geographic impact of R. Vree's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Vree with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Vree more than expected).
Fields of papers citing papers by R. Vree
This network shows the impact of papers produced by R. Vree. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Vree. The network helps show where R. Vree may publish in the future.
Co-authors
The 25 scholars most cited alongside R. Vree, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 100 | |
| 2 | 2010 | 63 | |
| 3 | 2015 | 46 | |
| 4 | 2009 | 36 | |
| 5 | 2015 | 35 | |
| 6 | 2013 | 32 | |
| 7 | 2012 | 23 | |
| 8 | 2010 | 22 | |
| 9 | 2011 | 6 | |
| 10 | 1990 | 5 | |
| 11 | [Quality of care and operative complications: comparison of the results of 3 medical departments]. | 2011 | 2 |
| 12 | [Phyllodes tumour: a rare, rapidly growing breast tumour]. | 2009 | 1 |
About R. Vree
R. Vree is a scholar working on Oncology, Pharmacology, General Health Professions, Pharmacology and Genetics, having authored 12 papers that have together received 371 indexed citations. Recurring topics across this work include Patient Satisfaction in Healthcare (3 papers), Patient-Provider Communication in Healthcare (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Estrogen and related hormone effects (3 papers), Inflammatory mediators and NSAID effects (3 papers), Cancer survivorship and care (2 papers), Colorectal Cancer Surgical Treatments (1 paper) and Abdominal Surgery and Complications (1 paper). The work is most often cited by research in Pharmacology (60 citations), Oncology (181 citations), Family Practice (9 citations), General Health Professions (87 citations) and Pathology and Forensic Medicine (44 citations). R. Vree has collaborated with scholars based in Netherlands and Belgium. Frequent co-authors include J. Kievit, Anne M. Stiggelbout, JCJM de Haes, K. van Groningen, Wendeline J. van der Made, Joyce Dijs-Elsinga, H.J. Smeets, Wilma Otten, Perla J. Marang‐van de Mheen and Hans Gelderblom. Their work appears in journals such as BMJ Quality & Safety, British Journal of Cancer, Journal of Clinical Oncology, Breast Cancer Research and Treatment and Quality of Life Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.